MARATTO

article · Journal of Agricultural Chemistry and Biotechnology

Bioremoval of Lead by Bacillus amyloliquefaciens Mpa 1034 Isolated from Wastewater Textile Factories at El-Mahala El-Kobra City, Egypt

2024Open accessMansoura University

Abstract

Heavy metals are considered serious environmental pollutants. Industrialization activity has put high amounts of toxic effluents, containing toxic metals into the environment. Therefore, there is an urgent need for industrial wastewater treatment. This study aims to lead bioremoval by active Pb-resistance bacterial cells. Only five bacterial isolates were obtained from industrial wastewater samples. Isolate NDSL2 withstood lead concentrations, MIC recorded at 180 μg/ml, and selected as the most resistant isolate. By depending on morphological and molecular characterizations, it was identified as Bacillus amyloliquefaciens MPA 1034 strain. The optimized conditions for improving Pb-bioremoval efficiency were established. Maximum bioremoval of lead has been revealed 70% by growing and active bacterial cells after 3 days at pH 7, in the presence of lactose, sodium nitrate and yeast extract. SEM, EDX and FTIR analysis confirmed Pd uptake in and/or bound on bacterial cells. Thus, it could be recommended to use Pb-resistance bacterial strain as bioremoval and remediate polluted industrial effluents.

Research topics

  • Chromium effects and bioremediation
  • Recycling and Waste Management Techniques
  • Analytical chemistry methods development

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/jacb.2024.281919.1079

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.